Home / Countries / Austria / HIV medicines

Austria · availability and reimbursement

HIV medicines in Austria

Of 26 verified HIV medicine records for Austria, 22 are available and reimbursed (85%), 2 are available but not reimbursed and 2 are not available. 16 further records are still under review.

85% of verified records reimbursed

Last checked 14/09/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 22

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey, Pifeltro, Prezista, Rekambys, Symtuza, Tivicay, Triumeq, Truvada, Vocabria, Vocabria / Rekambys

Available, not reimbursed 2

Rukobia, Sunlenca

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 16

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Emtriva, Epivir, Eviplera, Evotaz, Kivexa, Norvir, Retrovir, Reyataz, Rezolsta, Stribild, Viread, Yeytuo, Ziagen

See every medicine with its source →

More about Austria

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Austria profile

Neighbouring countries

SwitzerlandSlovakiaSloveniaItalyHungaryGermanyCzechia

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.